Skip to headerSkip to main contentSkip to footer
Get our Free E-newslettersGet our Free E-newsletters
Kiplinger logoLink to homepage
Get our Free E-newslettersGet our Free E-newsletters
Subscribe to Kiplinger
Subscribe to Kiplinger
Save up to 76%
Subscribe
Subscribe to Kiplinger
  • Store
  • Home
  • Investing
  • Retirement
  • Taxes
  • Personal Finance
  • Your Business
  • Wealth Creation
    • Podcasts
    • Economic Outlooks
    • Tools
    • Kiplinger's Personal Finance Magazine
    • The Kiplinger Letter
    • The Kiplinger Tax Letter
    • Kiplinger's Investing for Income
    • Kiplinger's Retirement Report
    • Store
    • Manage My E-Newsletters
    • My Subscriptions
Skip advert
  • Home
  • investing
  • stocks
stocks

5 Hot-Running Health Insurance Stocks to Buy

Many of us are unhappy with our health insurers.

by: Ken Berman
October 16, 2018
image

Getty Images

Skip advert

Many of us are unhappy with our health insurers. Premiums are high. Hospital bills can be large and deductibles for many policyholders are larger than ever.

But the world looks good if you own health insurance stocks. There are profits to be made managing government health care programs — Medicaid, public exchanges, the Children’s Health Insurance Program and Medicare. Because despite the confusion over health insurance, government health care expenditures continue to rise.

To wit, Medicare spending is projected grow 7.9% annually to 2023 with total expenditures of approximately $1.1 trillion. Meanwhile, Medicaid spending is estimated to grow 5.9% annually to 2023, when it will top $828 billion.

Here are five health insurance stocks to buy – all of which have advanced by double digits already in 2018. But don’t worry about being late to the party. There’s reason to expect more upside in these stocks because they need only to maintain a strategy at which they have proven adept: increase enrollments and contain medical costs.

Data is as of Oct. 15, 2018. Companies are listed in alphabetical order.

Skip advert
Skip advert
Skip advert

1 of 5

Centene

Centene logo

Centene

Skip advert
  • Market value: $29.6 billion

No one paid much attention when Centene (CNC, $139.42) joined the Affordable Care Act exchanges in 2014. But now it is the largest ACA player with 1.6 million marketplace members and continues to earn substantial profits from this program.

Centene is no one-trick pony, however. It wins about 81% of the Medicaid contracts it bids on, based on an analysis by Wells Fargo analysts.

Success in gaining new business has showed up on the top and bottom lines alike. Last year’s earnings grew to $5.03 per share, up from $4.43 in 2016. But there’s more growth to come for this health insurance stock, say Bank of America analysts, who estimate 2018 EPS of $6.95 on eye-popping revenues of $69 billion.

 

  • 10 Workhorse Health Care Stocks That Never Break a Sweat
Skip advert
Skip advert
Skip advert

2 of 5

Humana

Humana logo

Humana

Skip advert
  • Market value: $44.8 billion

Humana (HUM, $317.01) is a well-known health insurer. Humana’s balance sheet includes almost $19 billion in cash against just $5.3 billion in total debt, enabling the company to manage the twists and turns of the health care business in the U.S., and capitalize on the opportunities these twists and turns create.

Regarding the latter: In April, Humana teamed up with private equity players TPG Capital and Welsh, Carson, Anderson & Stowe to purchase hospice provider Curo for $1.4 billion. That deal followed Human’s $4 billion acquisition of Kindred at Home, which when combined with Curo created the nation’s largest hospice provider.

Before and shortly after CVS Health (CVS) announced its acquisition of Aetna (AET) in December of last year, there was speculation that Humana might be the next takeover target. Since then, however, that spotlight has come off Humana, and instead, the health insurance company is eyeing stronger ties with Walmart (WMT); the two companies currently have a prescription drug partnership.

While these machinations play out, Humana’s Medicare Advantage continues to grow rapidly. In August, Humana raised its adjusted EPS guidance for fiscal 2018 from to approximately $14.15 from its previous range of $13.70 to $14.10. Bank of America/Merrill Lynch analysts expect Humana to benefit from a recent increase in Medicare Advantage rates.

 

Skip advert
Skip advert
Skip advert

3 of 5

Molina Healthcare

Molina Healthcare logo

Molina Healthcare

Skip advert
  • Market value: $8.8 billion

Molina Healthcare (MOH, $138.57) is a managed care insurer that focuses on Medicaid. The growth in Medicaid is compelling (for insurers, but likely not for taxpayers), with government expenditures of $566 billion in 2016 projected to expand to $696 billion in 2020.

Molina reported second-quarter earnings in August that benefited from downsizing, improved productivity and debt reduction. Based on these improvements, management raised its EPS guidance substantially, from a range of $4-$4.50 per share to $7.39-$7.59, or an increase of 68%-85% on the higher and lower ends, respectively.

It’s not just Medicaid spending that is fueling optimism behind Molina and similar health insurance stocks. In 2017, a management shake-up resulted in Molina’s board letting go of CEO J. Mario Molina and CFO John Molina, the sons of founder C. David Molina. Joseph M. Zubretsky, former CEO of Hanover Insurance, took the reins during the fourth quarter of that year, and the company’s progress under his leadership during Q1 and Q2 of this year has been material.

 

  • The Best and Worst Presidents (According to the Stock Market)
Skip advert
Skip advert
Skip advert

4 of 5

UnitedHealth Group

UnitedHealth Group logo

UnitedHealth Group

Skip advert
  • Market value: $259.0 billion

UnitedHealth Group (UNH, $260.25) is the largest health insurer in the United States, and the bulk of its business is tied to government programs that are growing at healthy rates. The stock has regularly hit new highs this year and is up 21% year-to-date.

About 10,000 baby boomers turn 65 daily and qualify for Medicare, which is UnitedHealth’s largest business segment, accounting for $66 billion of its $163 billion in revenues last year. UnitedHealth’s fastest-growing business, which it calls UnitedHealthcare Community & State, is tied to Medicaid spending (which is growing around 6% annually). Between 2015 and 2017, Community & State revenues jumped 29%, from $28.9 billion to $37.4 billion. These businesses are important because the employers and individual insurance division shrunk between 2016 and 2017, though it remains above 2015 levels.

Analysts are bullish on UNH because of its diversified product line, which they feel will enable it to adapt to changing government regulations and seize growth opportunities as they appear.

 

Skip advert
Skip advert
Skip advert

5 of 5

WellCare Health Plans

WellCare Health Plans logo

WellCare Health Plans

Skip advert
  • Market value: $15.8 billion

WellCare Health Plans (WCG, $305.99) earns most of its revenue from running Medicare programs for the government. Remember” Medicare spending is growing at nearly 8%, according to the Centers for Medicare and Medical Services. Total spending in 2016 – the latest year for which actual figures are available – was $672 billion with projections for $1.1 trillion in 2023.

It’s a huge pie, and Wellcare is an able, acquisitive player. The company recently completed the acquisition of several Meridian health plan companies, giving it a top market position in two states, an accretive addition to earnings — according to the company’s guidance and analyst reports — and the option to enter the exchange business.

This comes on top of what Bank of America analysts forecast as robust organic growth, with 2017 earnings per share of $8.52 rising to $10.90 in 2018 – a roughly 28% improvement.

 

  • 7 Health Care Stocks to Buy for Robust Returns
Skip advert
Skip advert
Skip advert
  • dividend stocks
  • health insurance
  • bonds
  • insurance
  • stocks
  • Humana (HUM)
Share via EmailShare on FacebookShare on TwitterShare on LinkedIn
Skip advert
Skip advert
Skip advert
Skip advert

Recommended

Stock Market Today (6/24/22): Stocks Stick the Landing in Successful Short Week
Stock Market Today

Stock Market Today (6/24/22): Stocks Stick the Landing in Successful Short Week

Small hints that inflation might have peaked and that the U.S. might evade recession stoked broad buying Friday.
June 24, 2022
Could Buffett Buy Out Occidental (OXY)?
stocks

Could Buffett Buy Out Occidental (OXY)?

All in, Berkshire Hathaway now owns a third of energy firm Occidental Petroleum. One analyst thinks Buffett might make a play for the rest.
June 24, 2022
Kiplinger's Weekly Earnings Calendar
stocks

Kiplinger's Weekly Earnings Calendar

Check out our earnings calendar for the upcoming week, as well as our previews of the more noteworthy reports.
June 24, 2022
Stock Market Today (6/23/22): Safety-Seeking Investors Drive Stocks Higher
Stock Market Today

Stock Market Today (6/23/22): Safety-Seeking Investors Drive Stocks Higher

Investors piled into bonds and yield-bearing sectors such as utility stocks and consumer staples Thursday as the economy's fate continues to be shroud…
June 23, 2022

Most Popular

I’m Retired. Should I Pay Off My Mortgage?
retirement

I’m Retired. Should I Pay Off My Mortgage?

It’s a simple question. The right answer for you could depend on this: Where would you pull the money from to do it?
June 20, 2022
Your Guide to Roth Conversions
Special Report
Tax Breaks

Your Guide to Roth Conversions

A Kiplinger Special Report
February 25, 2021
7 Standout Places to Retire
Best Places

7 Standout Places to Retire

We picked cities across the U.S. that are affordable and offer the amenities retirees value most. Plus, one of them is bound to be close to family.
June 17, 2022
  • Customer Service
  • About Us
  • Advertise With Us (PDF)
  • Privacy Policy
  • Cookie Policy
  • Kiplinger Careers
  • Accessibility
  • Privacy Preferences

Subscribe to Kiplinger's Personal Finance

Be a smarter, better informed investor.
Save up to 76%Subscribe to Kiplinger's Personal Finance
Do Not Sell My Information

Kiplinger is part of Future plc, an international media group and leading digital publisher. Visit our corporate site www.futureplc.com
© Future US LLC, 10th floor, 1100 13th Street NW, Washington, DC 20005. All rights reserved.

Follow us on InstagramFollow us on FacebookFollow us on TwitterConnect on LinkedInConnect on YouTube